Cargando…
PMON61 Evaluation of elevated IGF-1 in patients without clinical evidence of acromegaly
INTRODUCTION: Insulin-like growth factor-1 (IGF-1) acts downstream of growth hormone mediating many of its effects. It is the recommended screening test for acromegaly, in evaluating pituitary incidentalomas and possible hypopituitarism. Case-based observations suggest that elevated IGF-1 may occur...
Autores principales: | Careless, Laura, Inder, Warrick, Pretorius, Carel, Hayes, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625597/ http://dx.doi.org/10.1210/jendso/bvac150.1160 |
Ejemplares similares
-
PMON117 IGF-1 Testing: Diagnostic Pitfalls
por: Perez-Martinez, Sebastian
Publicado: (2022) -
PMON154 Cardiovascular Complications in Acromegaly-A National Inpatient Sample Analysis
por: Thota, Geethika, et al.
Publicado: (2022) -
PMON101 Fluctuating Insulin Requirements in Untreated Acromegaly: From 200-to-0
por: Bellavia, Lauren, et al.
Publicado: (2022) -
PMON161 Decreased serum Wnt antagonist levels in patients with active acromegaly
por: Chen, Huan, et al.
Publicado: (2022) -
PMON104 Sellar Gangliocytoma-Pituitary Neuroendocrine Tumor (PitNET) Presenting As Acromegaly
por: Aurora, John, et al.
Publicado: (2022)